Kezar Life Sciences Inc’s recently made public that its Chief Legal Officer Schiller Mark C. unloaded Company’s shares for reported $3879.0 on Jul 02 ’24. In the deal valued at $0.58 per share,6,688 shares were sold. As a result of this transaction, Schiller Mark C. now holds 33,007 shares worth roughly $24755.25.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wells Fargo downgraded its Kezar Life Sciences Inc [KZR] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Mkt perform”. Wells Fargo began covering KZR with “an Overweight” recommendation on December 08, 2021. William Blair started covering the stock on July 16, 2018. It rated KZR as “an Outperform”.
Price Performance Review of KZR
On Tuesday, Kezar Life Sciences Inc [NASDAQ:KZR] saw its stock fall -2.86% to $0.75. Over the last five days, the stock has lost -3.79%. Kezar Life Sciences Inc shares have fallen nearly -20.79% since the year began. Nevertheless, the stocks have risen 2.79% over the past one year. While a 52-week high of $1.13 was reached on 03/01/24, a 52-week low of $0.52 was recorded on 09/26/24. SMA at 50 days reached $0.6841, while 200 days put it at $0.7546.
Levels Of Support And Resistance For KZR Stock
The 24-hour chart illustrates a support level at 0.7208, which if violated will result in even more drops to 0.6912. On the upside, there is a resistance level at 0.7893. A further resistance level may holdings at 0.8282. The Relative Strength Index (RSI) on the 14-day chart is 48.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0491, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.39%. Stochastics %K at 15.60% indicates the stock is a buying.
How much short interest is there in Kezar Life Sciences Inc?
A steep rise in short interest was recorded in Kezar Life Sciences Inc stocks on 2024-10-15, growing by 0.33 million shares to a total of 1.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 0.87 million shares. There was a rise of 27.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 16, 2018 when Wells Fargo began covering the stock and recommended ‘”an Outperform”‘ rating along with a $30 price target.
